Trial Profile
Circulating follicular helper T cells and regulatory T cells in patients with autoimmune rheumatic diseases treated with B cell depletion therapy (rituximab)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Dec 2015
Price :
$35
*
At a glance
- Drugs Rituximab (Primary)
- Indications Granulomatosis with polyangiitis; Systemic lupus erythematosus
- Focus Pharmacodynamics
- 14 Dec 2015 New trial record